Post Inflammatory Hyperpigmentation Completed Phase 4 Trials for Azelaic acid (DB00548)

Also known as: Post inflammatory pigmentation change / Postinflammatory hyperpigmentation

IndicationStatusPhase
DBCOND0045798 (Post Inflammatory Hyperpigmentation)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01038869Efficacy and Safety Study of Finacea to Treat Acne Vulgaris and Post-Inflammatory Hyperpigmentation (PIH)Treatment